Politics and policy

Insight into federal and state health care legislation & CMS regulation

Richard Mark Kirkner
Groups fighting the disease are counting on people in health care’s ‘deep state’ to deliver on the commitment to end the occurrence of new cases of HIV/AIDS by 2030.
Legislation & Regulation
Richard Mark Kirkner
But critics of the Center for Medicare and Medicaid Innovation see too much power and money accruing to the ACA-created skunkworks.
News & Commentary
Even as the health insurance industry comes under increasing political fire (Medicare for All, anyone?), it continues to lure beneficiaries into Medicare Advantage, with 2019 looking to be the best year ever for the program. Of course, as has been noted, MA plans may have an unfair advantage over traditional…
Jan Greene
In another international comparison, the health status of American women lags behind that of women in other developed countries.
Cover Story
Timothy Kelley
Is MA a ripoff of taxpayers, a godsend for integrated, cost-effective care, or somehow both? You can’t take a stand on this question from 30,000 feet. So let us guide you through the valley of details.
Joseph Burns
Gretchen Jacobson, Kaiser Family Foundation
While researchers see flaws in the MA program, the federal government seems content to pay insurers billions of dollars in bonuses each year—at least for now.
Legislation & Regulation
Richard Mark Kirkner
Verma, CMS say bringing step therapy to Part B will save plans and beneficiaries money. Critics see perverse incentives and circumvention of normal rulemaking.
Legislation & Regulation
Richard Mark Kirkner
The FDA commissioner has an 11-step ‘action plan’ to get biosimilars out of a repeat mode of unrealized potential. But issues like interchangeability still need clarifying if biosimilars are to have a major effect on drug expenditures.